Previous 10 | Next 10 |
Analyst Hosted Event to Discuss Refocused Business, Cost Reductions and Turnaround Plan Buffalo, New York--(Newsfile Corp. - January 12, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to ...
Sale Will Significantly Reduce Operating Expenses, Ultimately Reduce Debt by $5.2 Million Buffalo, New York--(Newsfile Corp. - December 28, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies ...
Sale and Related Actions Ultimately Expected to Reduce Debt Principal by $5.2 Million Buffalo, New York--(Newsfile Corp. - December 14, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to i...
2023-12-04 09:10:25 ET More on 22nd Century 22nd Century to sell its hemp/cannabis franchise, stock jumps ~13% after hours 22nd Century Group prices public offering to raise $5.25M Seeking Alpha’s Quant Rating on 22nd Century Historical earnings data f...
BUFFALO, N.Y., Dec. 04, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the exercise of warrants by certain holders pur...
2023-11-29 11:29:00 ET A New York-based %Pharmaceutical company is stealing the show on Wednesday following a key appointment of a new executive. According to a release this morning, %22ndCenturyGroup (Nasdaq: XXII) appointed Lawrence Firestone as chairman and CEO. This announceme...
2023-11-29 07:36:04 ET More on 22nd Century 22nd Century to sell its hemp/cannabis franchise, stock jumps ~13% after hours 22nd Century Group prices public offering to raise $5.25M Seeking Alpha’s Quant Rating on 22nd Century Historical earnings data f...
BUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the appointment of&...
2023-11-27 17:00:23 ET 22nd Century Group ( NASDAQ: XXII ) on Monday said it would sell all of its GVB Biopharma hemp/cannabis operations, about a year and a half after acquiring the business. XXII stock surged 12.8% to $0.24 after hours. XXII will sell the operations to...
BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has ...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...